Pharmaceutical giants including Amgen, Merck and Gilead formed a coalition Wednesday to lobby against a proposed overhaul of federal antitrust guidelines.
In refusing to freeze Medicare drug price negotiations, a federal judge in Ohio on Friday appeared to throw cold water on one of the pharmaceutical industry's main arguments against the Inflation Reduction Act.
PBMs are stuck between a rock and a hard place, facing congressional scrutiny and pharmaceutical-industry-backed efforts to reform the multibillion-dollar industry.
Drugmaker Boehringer Ingelheim Pharmaceuticals Inc. is preparing to negotiate with Medicare on a price for its diabetes drug Jardiance, the company told Bloomberg Law Wednesday.